Suppliers / ORIL Industrie

ORIL Industrie

France Updated 9 July 2026

ORIL Industrie is an API manufacturer based in France. It holds one active US drug master file and 4 valid CEPs across a filed portfolio of 7 molecules. Its GMP standing is certified by ANSM (FR). Its most recent recorded inspection, by US FDA, closed on 6 April 2023 as VAI.

1
active US DMFs
4
valid CEPs
4
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 April 2023 VAI US FDA
  • 14 September 2018 VAI US FDA
  • 17 October 2014 VAI US FDA
  • 9 December 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
BOLBEC, France Not on file
BOLBEC, France Not on file
France, France 1000435915
Bolbec, France Not on file

What they file, and where

Molecule Regulators Docs
Gliclazide EDQM, SFDA (Saudi Arabia) 2
Indapamide EDQM, SFDA (Saudi Arabia) 2
Ivabradine SFDA (Saudi Arabia), US FDA 2
Perindopril SFDA (Saudi Arabia) 2
Atorvastatin SFDA (Saudi Arabia) 1
Perindopril Tert-Butylamine EDQM 1
Rilmenidine Dihydrogen Phosphate EDQM 1

Also appears on these molecule pages

Gliclazide API Indapamide API Perindopril API Atorvastatin API

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) None 50

Comparing suppliers?

Choose your molecules and target markets. ORIL Industrie comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 April 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates